Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low-or intermediate-risk disease

被引：0
|
作者：
Arvold, N. D.
Chen, M.
Moul, J. W.
Moran, B. J.
Dosoretz, D. E.
Banez, L. L.
Katin, M. J.
Braccioforte, M. H.
D'Amico, A. V.
机构：
[1] Harvard Radiat Oncol Program, Boston, MA USA
[2] Univ Connecticut, Storrs, CT USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Prostate Canc Fdn Chicago, Westmont, IL USA
[5] 21st Century Oncol, Ft Myers, FL USA
[6] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 07期
关键词：
D O I：
10.1200/jco.2011.29.7_suppl.198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
198
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Survival of Low-Risk and Intermediate-Risk Prostate Cancer Patients Treated with IMRT Or Brachytherapy
    Podder, T.
    Dey, A.
    Datta, S.
    Biswas, T.
    MEDICAL PHYSICS, 2020, 47 (06) : E318 - E318
  • [22] Hormonal Therapy or External Beam Radiation with Brachytherapy and the Risk of Death from Prostate Cancer in Men with Intermediate Risk Prostate Cancer
    Rosenberg, J. E.
    Chen, M.
    Nguyen, P. L.
    Braccioforte, M. H.
    Moran, B. J.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S367 - S368
  • [23] Re: The Likelihood of Death from Prostate Cancer in Men with Favorable or Unfavorable Intermediate-Risk Disease Editorial Comment
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2014, 192 (02): : 422 - 422
  • [24] Radiotherapy in low and intermediate-risk prostate cancer
    Yalman, Deniz
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2013, 12 (02): : 86 - 91
  • [25] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
  • [26] Personalizing the Management of Men with Intermediate-risk Prostate Cancer
    D'Amico, Anthony V.
    EUROPEAN UROLOGY, 2013, 64 (06) : 903 - 904
  • [27] Heterogeneity in early oncologic outcomes among men with NCCN intermediate-risk prostate cancer treated with radical prostatectomy.
    Ghabili, Kamyar
    Nguyen, Kevin
    Lu, Amanda
    Hsiang, Walter
    Shuch, Brian M.
    Leapman, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [28] Hormonal Therapy or External-Beam Radiation With Brachytherapy and the Risk of Death From Prostate Cancer in Men With Intermediate Risk Prostate Cancer
    Rosenberg, Jonathan E.
    Chen, Ming-Hui
    Nguyen, Paul L.
    Braccioforte, Michelle H.
    Moran, Brian J.
    D'Amico, Anthony V.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (01) : 21 - 25
  • [29] Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer
    Freedland, SJ
    Kane, CJ
    Amling, CL
    Aronson, WJ
    Presti, JC
    Terris, MK
    JOURNAL OF UROLOGY, 2006, 175 (04): : 1298 - 1302
  • [30] INTERMEDIATE-RISK PROSTATE CANCER, ANDROGEN DEPRIVATION THERAPY AND THE RISK OF DEATH
    Pickles, Tom
    Tyldesley, Scott
    Keyes, Mira
    Morris, W. James
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S27 - S27
12345